Instalab
logoInstalab

Lead

24 Hour Urine Test
See how much lead your body is clearing right now, a real-time read on recent exposure.
4.9 (2,631 reviews)
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Collect your sample
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Lead test?

This test is most useful if any of these apply to you.

Working Around Lead on the Job
If your work involves lead exposure, this test tracks how much your body cleared over the past day.
Living in Older Housing
Pre-1978 paint, old plumbing, and renovation dust are common sources of ongoing exposure worth measuring.
Already Managing Kidney Issues
Lead is directly toxic to kidneys, and higher urinary lead is linked to faster decline and higher mortality.
Checking a Suspected Exposure
If you think you have been exposed through hobbies, imported goods, or contaminated water, this test can catch recent uptake.

About Lead

Lead is one of the few metals with no known biological role and no safe level of exposure. A 24-hour urine collection captures every drop of urine you produce over a full day, then measures the total amount of lead your kidneys removed from your blood in that window. That total gives you a snapshot of how much lead your body is actively clearing, which reflects what you have been exposed to recently or what your body is mobilizing from storage.

This test is most often ordered in occupational or medical settings, but it can also be useful if you suspect an ongoing exposure at home, from old paint, imported ceramics, contaminated water, or hobbies involving soldering, ammunition, or stained glass. It works best as part of a picture that also includes a blood lead level, not as a standalone number.

What This Test Actually Measures

The lab quantifies the mass of elemental lead excreted in your urine over exactly 24 hours. Because urine lead reflects what the kidneys have cleared recently, it changes more rapidly than blood lead, which itself has a half-life of about 35 days. Lead stored in bone can persist for years to decades. That means a 24-hour urine result tells you more about recent excretion and mobilizable lead than about your long-term body burden.

Two versions of this test exist. The routine, unprovoked collection measures baseline daily excretion. The provoked or mobilization version measures excretion after you receive a chelating drug (a medication designed to bind heavy metals and pull them out of tissues), which shifts stored lead into a form your kidneys can dump. Both use the same 24-hour collection format, but they answer different questions and are interpreted differently.

Why Blood Lead Is Usually the Primary Test

Across the research, whole-blood lead is the biomarker that best distinguishes people with different average lead exposure. One large biomonitoring study concluded that urine lead should not be used as the primary marker of lead exposure, and another found that at low exposure levels, urine lead cannot reliably predict blood lead concentrations. The relationship between urine and blood lead is real but weakens sharply at lower blood lead concentrations.

That said, a well-collected 24-hour urine lead sample correlates fairly strongly with blood lead in healthy adults, with a correlation of about 0.77 (a number close to 1.0 would mean the two values move almost perfectly together). Once you adjust the urine for how dilute it is, the reproducibility from day to day is fairly good, with a measure of consistency between roughly 0.75 and 0.90 in stable non-smokers. So the test is useful, but it is a supporting player rather than the star.

How to Read a High or Low Result

A high 24-hour urine lead suggests one of three things: you have had recent or ongoing exposure, your body is mobilizing lead out of stored sites (which happens naturally with bone turnover, pregnancy, breastfeeding, or aggressive weight loss), or you have been given a chelating drug. Interpreting a high number requires knowing which of these applies.

A low 24-hour urine lead usually means little measurable excretion, which is expected in most people without recent exposure. On its own, a low value is reassuring, but it does not rule out chronic body burden stored in bone. Someone with substantial old lead exposure from childhood or a former occupation can have low urinary excretion today while still carrying decades of accumulated lead in their skeleton, which is why bone lead measurement or provoked testing is sometimes used in high-suspicion cases.

Cardiovascular Disease and Mortality

Lead damages blood vessels and the heart at levels once considered safe. In a US analysis of 14,305 adults, higher urinary lead was associated with about 18% higher risk of cardiovascular death in models that accounted for competing causes. In a separate group of 6,453 adults with high blood pressure, people in the highest quarter of blood lead had roughly 73% higher risk of dying from any cause compared with those in the lowest quarter, and each unit increase in blood lead was linked to about 23% higher mortality risk.

A landmark analysis of 14,289 US adults followed for a median of 19.3 years found that going from a blood lead near the tenth percentile to the ninetieth percentile was associated with about 37% higher all-cause mortality, 70% higher cardiovascular mortality, and roughly twice the risk of dying from ischemic heart disease. Urine and blood lead were also linked to arterial stiffness in lead-exposed workers, an early sign of vascular aging.

Kidney Disease

Lead is directly toxic to the tubules of the kidney, and the kidneys are also the exit route for most excreted lead. In a US cohort of 2,320 adults with chronic kidney disease followed for a median of about 6.5 years, people in the highest quarter of urinary lead had roughly 77% higher risk of dying from any cause compared with those in the lowest quarter. Each unit increase in urine lead was associated with about 21% higher mortality, an association that held after adjustment for age, lifestyle, and other conditions.

In occupationally exposed workers, urinary KIM-1 (a marker released when kidney tubules are injured) correlated better with blood lead than older kidney markers, suggesting that lead can produce measurable kidney stress even before standard tests move. A separate randomized trial in people with chronic kidney disease and a high-normal lead burden found that weekly chelation over 27 months improved kidney filtration by 2.1 mL/min/1.73 m², while the untreated group lost 6.0 mL/min/1.73 m² over the same period.

Blood, Nerves, and Development

Beyond kidneys and heart, lead impairs the enzyme your body uses to build hemoglobin, the oxygen-carrying protein in red blood cells. This is why urinary aminolevulinic acid (ALA), a chemical that piles up when this enzyme is blocked, has long been used as a marker of early lead effect. Chronic lead exposure has been linked to anemia, peripheral nerve dysfunction, cognitive decline in adults, and irreversible neurodevelopmental harm in fetuses and children. Urine lead is not the sharpest tool for these outcomes in isolation, but a high value should prompt broader evaluation.

Cancer Associations

A systematic review of lead in blood and urine found that higher lead levels are consistently associated with higher overall cancer incidence and mortality, particularly cancers of the gastrointestinal tract and the bladder and urinary tract. Inorganic lead compounds are classified by the International Agency for Research on Cancer as probable human carcinogens (Group 2A), while lead metal itself is classified as possibly carcinogenic to humans (Group 2B). The biology behind the cancer link is not as well mapped as lead's effects on the heart and kidneys.

Why One Reading Is Not Enough

Urine lead behaves differently over different time windows. Day-to-day reproducibility in stable healthy adults is decent, with consistency scores between 0.75 and 0.90. But over three months, urine lead can vary substantially in the same person, with reproducibility scores between 0.01 and 0.29 in one study of healthy men. A single 24-hour collection reflects the day it was taken. It does not reliably represent your average exposure over weeks or months.

For proactive tracking, get a baseline, then repeat in 3 to 6 months if you are making changes (removing an exposure source, doing renovation cleanup, changing water filtration). If you are being monitored during or after chelation, retest on the schedule your clinician recommends, which is usually more frequent. If your baseline is low and your exposures have not changed, at least annual monitoring is reasonable if you have known risk factors, and every 2 to 3 years otherwise. Pair urine lead with a blood lead level whenever possible, since the two together give a much clearer picture than either alone.

When Results Can Be Misleading

The most common cause of a misleading result is an incomplete collection. If you forget a void, spill a portion, or start the 24-hour clock at the wrong time, the total lead will be systematically low. Because 24-hour excreted mass depends on capturing every drop of urine over exactly 24 hours, technique matters more here than for a routine blood test.

  • Hydration and urine flow: urinary lead excretion is tied to how fast urine is being produced. Very dilute or very concentrated urine can shift the result even when body lead has not changed. Labs partially correct for this with a creatinine or specific gravity adjustment.
  • Diurnal timing: urinary lead excretion is lowest overnight and rises during the day. Even within a 24-hour collection, an unusual sleep or activity pattern can nudge the total.
  • Recent chelation or high-dose vitamin C or minerals: these can mobilize stored lead and temporarily raise urinary excretion without reflecting new exposure. Tell your ordering clinician about any recent supplements or medical treatments.
  • Sample contamination: in one isotope study, about 10% of paired blood and urine measurements were outliers, usually because of lead contamination during urine collection. Use only the container the lab provides.

Provoked Testing Is a Different Question

If you have received a chelating drug like EDTA or DMSA (succimer) before the 24-hour collection, the test is called a mobilization or provoked test. This version measures how much lead your kidneys can pull out when a drug is dragging it out of soft tissues and some bone. Provoked urine lead peaks within 2 to 3 hours of oral DMSA and about 6 hours after intravenous EDTA. With DMSA specifically, the excretion typically climbs 5- to 20-fold above baseline during a 5-day course. Head-to-head comparisons suggest EDTA produces roughly threefold higher urinary lead than DMSA, because the two drugs reach different lead storage pools.

Provoked testing has real diagnostic value, especially in occupational medicine and in evaluating chronic exposure, but its clinical usefulness is strongest when blood lead is already substantially elevated. In the general public, most experts do not recommend provoked testing as a routine screen. The drug itself has side effects, the interpretation depends on the drug and dose, and there are simpler ways to detect current exposure.

What to Do With an Unexpected Result

An unexplained high 24-hour urine lead should trigger a workup, not a wait. Get a blood lead level, since the two together tell you whether the exposure is recent (blood lead rises) or a chronic body burden mobilizing out (blood lead may be lower than expected). Ask for a complete blood count with red cell indices to check for anemia, a basic metabolic panel to assess kidney function, and if kidney concern is high, urine albumin and a cystatin C-based estimate of filtration rate. If you have known occupational exposure, an occupational medicine specialist should be involved. If the exposure source is unclear, an environmental health assessment of your home, hobbies, and water supply is the next step.

For borderline results, a repeat 24-hour collection under standardized conditions is more useful than jumping to intervention. The goal is to distinguish a genuine ongoing exposure from a testing artifact or brief mobilization event.

Sex, Age, and Population Patterns

In healthy adults, men excrete more lead in urine over 24 hours than women. In one population study, average excretion was 64 nmol per 24 hours in adult men versus 40 nmol per 24 hours in women, a difference of about 60%. Urinary lead output also rises with age until roughly 50, reflecting decades of accumulated exposure being slowly released. Rural residents can have higher urinary lead than urban residents in some regions, depending on soil, water, and occupational patterns. Interpret your number in the context of who you are, not against a single fixed number.

What Moves This Biomarker

Evidence-backed interventions that affect your Lead level

Increase
Chelation therapy with intravenous EDTA
EDTA infusion rapidly increases urinary lead excretion by binding lead in the blood and soft tissues so the kidneys can dump it. In a pharmacokinetic study, urinary lead rose substantially after a 1 g dose, a roughly 30-fold jump peaking at 6 hours. In a 27-month randomized trial of weekly 1 g EDTA infusions in adults with chronic kidney disease and a high-normal lead burden, kidney filtration improved by 2.1 mL/min/1.73 m² in the chelation group versus a 6.0 mL/min/1.73 m² decline in the control group. Higher urine lead here is a treatment goal, not a warning.
MedicationStrong Evidence
Increase
Chelation with oral DMSA (succimer)
Oral DMSA increases urinary lead excretion by 5- to 20-fold above baseline over a 5-day course, and blood lead often drops to half or less of the pretreatment value. DMSA 30 mg/kg/day is more effective than 10 or 20 mg/kg/day. This is the standard oral chelator for moderate lead poisoning in children and adults. Rising urine lead here is the intended effect and correlates with real reduction in body burden.
MedicationStrong Evidence
Increase
Ongoing occupational lead exposure (industrial work, battery manufacturing, smelting, ammunition, radiator repair)
Sustained exposure at work raises both blood and urine lead, and 24-hour urinary lead rises proportionally with airborne and blood lead in occupational cohorts. This is not incidental; it reflects real absorption of lead into the body, which drives kidney injury, hypertension, cognitive changes, and long-term cardiovascular risk. Reducing exposure lowers both blood and urine lead over months.
LifestyleStrong Evidence
Increase
Household lead exposure (deteriorating paint, contaminated dust, old plumbing, imported ceramics or cosmetics)
Home-based exposures raise body lead over weeks to months, and this shows up in both blood and urine measurements. In a study of at-risk families, home-based education, housing remediation, and relocation each led to significant reductions in blood lead over time. Persistent household exposure is one of the most common non-occupational drivers of a high result, especially in older housing built before lead paint was banned.
LifestyleModerate Evidence
Increase
Modified citrus pectin
In a small pediatric pilot study, modified citrus pectin increased 24-hour urinary lead by about 132% and lowered blood lead substantially on average. The proposed mechanism is that the pectin binds lead in the gut and possibly mobilizes it from tissues, though the evidence remains preliminary and has not been reproduced in larger controlled trials.
SupplementModerate Evidence

Frequently Asked Questions

References

25 studies
  1. Sallsten G, Ellingsen D, Berlinger B, Weinbruch S, Barregard LEnvironmental Research2022
  2. Sommar J, Hedmer M, Lundh T, Nilsson L, Skerfving S, Bergdahl IJournal of Exposure Science and Environmental Epidemiology2013
  3. Martinez-morata I, Sobel M, Tellez-plaza M, Navas-acien a, Howe CG, Sanchez TCurrent Environmental Health Reports2023
  4. Gulson B, Cameron M, Smith AJ, Mizon K, Korsch M, Vimpani G, Mcmichael a, Pisaniello D, Jameson CW, Mahaffey KEnvironmental Research1998
  5. Lee B, Schwartz B, Stewart W, Ahn KOccupational and Environmental Medicine1995